In this issue:
12-weekly zoledronic acid for bone metastases?
Extending AI adjuvant therapy to 10 years
Letrozole ± palbociclib in advanced breast cancer
Atezolizumab vs. docetaxel in previously treated NSCLC
Dexamethasone ±WBRT for NSCLC with brain metastases
Ipilimumab + etoposide/platinum in extensive-stage SCLC
Chemoprevention options for high-risk colorectal malignancies
Wait longer for surgery post-radiochemotherapy in rectal cancer?
Prognosis of patients with peritoneal metastatic CRC
Adjuvant bevacizumab + capecitabine for CRC?
Please login below to download this issue (PDF)